Humana Crecimiento futuro

Future controles de criterios 3/6

Se prevé que los ingresos de Humana disminuyan a un ritmo anual de 1.1%, mientras que se prevé que sus beneficios anuales crezcan a un ritmo de 25.9% por año. Se espera que el BPA crezca en un 27.4% al año.

Información clave

29.2%

Tasa de crecimiento de los beneficios

27.4%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare	31.8%
Tasa de crecimiento de los ingresos	-1.3%
Rentabilidad financiera futura	n/a
Cobertura de analistas	Low
Última actualización	26 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Humana AB (publ) (STO:HUM) Just Released Its Full-Year Earnings: Here's What Analysts Think

Feb 12

Recent updates

Humana AB (publ) (STO:HUM) Doing What It Can To Lift Shares

Apr 09

Humana AB (publ) (STO:HUM) Just Released Its Full-Year Earnings: Here's What Analysts Think

Feb 12

Humana AB (publ)'s (STO:HUM) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Mar 11

Did Humana AB (publ) (STO:HUM) Insiders Buy Up More Shares?

Feb 28

Do Humana's (STO:HUM) Earnings Warrant Your Attention?

Feb 15

Previsiones de crecimiento de beneficios e ingresos

OM:HUM - Estimaciones futuras de los analistas y datos financieros pasados (SEK Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2025	9,430	238	443	415	3
12/31/2024	10,397	217	356	292	1
3/31/2024	9,621	146	484	654	N/A
12/31/2023	9,649	176	451	621	N/A
9/30/2023	9,684	228	316	508	N/A
6/30/2023	9,659	250	414	606	N/A
3/31/2023	9,491	232	414	606	N/A
12/31/2022	9,203	210	441	633	N/A
9/30/2022	8,869	183	490	520	N/A
6/30/2022	8,530	203	465	582	N/A
3/31/2022	8,347	242	481	598	N/A
12/31/2021	8,186	276	572	689	N/A
9/30/2021	8,000	293	593	813	N/A
6/30/2021	7,896	279	670	803	N/A
3/31/2021	7,825	272	603	736	N/A
12/31/2020	7,771	262	528	661	N/A
9/30/2020	7,750	230	543	613	N/A
6/30/2020	7,739	249	595	703	N/A
3/31/2020	7,670	197	434	662	N/A
12/31/2019	7,446	188	403	631	N/A
9/30/2019	7,247	222	327	556	N/A
6/30/2019	7,005	196	173	416	N/A
3/31/2019	6,774	245	265	425	N/A
12/31/2018	6,714	246	158	332	N/A
9/30/2018	6,600	228	252	396	N/A
6/30/2018	6,550	197	210	346	N/A
3/31/2018	6,541	199	90	216	N/A
12/31/2017	6,542	194	N/A	241	N/A
9/30/2017	6,635	195	N/A	-185	N/A
6/30/2017	6,684	241	N/A	-153	N/A
3/31/2017	6,540	226	N/A	-143	N/A
12/31/2016	6,362	148	N/A	-161	N/A
9/30/2016	6,140	139	N/A	255	N/A
6/30/2016	5,868	-11	N/A	202	N/A
3/31/2016	5,713	-53	N/A	233	N/A
12/31/2015	5,593	28	N/A	274	N/A
12/31/2014	5,065	38	N/A	156	N/A
12/31/2013	3,489	111	N/A	196	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (26.4% al año) de HUM es superior a la tasa de ahorro (0.9%).

Beneficios vs. Mercado: Se prevé que los beneficios (26.4% al año) de HUM crezcan más rápidamente que el mercado Swedish (13.1% al año).

Beneficios de alto crecimiento: Se espera que los beneficios de HUM crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos de HUM disminuyan en los próximos 3 años (-1.1% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos de HUM disminuyan en los próximos 3 años (-1.1% al año).

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de HUM se prevé que sea elevada dentro de 3 años.

Humana Crecimiento futuro

Future controles de criterios 3/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Consensus revenue estimates increase by 11%, EPS downgraded

Humana AB (publ) (STO:HUM) Just Released Its Full-Year Earnings: Here's What Analysts Think

Consensus EPS estimates increase by 15%

Price target increased by 41% to kr23.50

Price target decreased by 23% to kr45.67

Price target decreased by 7.8% to kr59.33

Recent updates

First quarter 2024 earnings released: EPS: kr0.44 (vs kr1.07 in 1Q 2023)

Investor sentiment improves as stock rises 15%

Humana AB (publ) (STO:HUM) Doing What It Can To Lift Shares

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Humana AB (Publ) Announces Nomination Committee for the Annual General Meeting 2024

Humana Announces Board Changes, Effective May 1, 2024

Consensus revenue estimates increase by 11%, EPS downgraded

Humana AB (publ) (STO:HUM) Just Released Its Full-Year Earnings: Here's What Analysts Think

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Humana Announces the Resignation of Johanna Rastad as President

Humana AB (publ) to Report Fiscal Year 2023 Results on Apr 03, 2024

New major risk - Revenue and earnings growth

Consensus EPS estimates increase by 15%

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Humana AB (publ), Annual General Meeting, May 07, 2024

Humana AB (publ) to Report Q4, 2023 Results on Feb 08, 2024

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improves as stock rises 23%

Price target increased by 41% to kr23.50

New major risk - Share price stability

Investor sentiment improves as stock rises 42%

Humana AB (publ) Announces Board Appointments

Full year 2022 earnings: EPS exceeds analyst expectations

Investor sentiment improves as stock rises 16%

Does Humana (STO:HUM) Have A Healthy Balance Sheet?

Full year 2022 earnings: EPS exceeds analyst expectations

Sören Mellstig Not Stands for the Re-Election to the Board of Humana AB (Publ)

Price target decreased by 23% to kr45.67

Humana AB (publ) to Report Fiscal Year 2022 Results on Apr 03, 2023

At kr20.50, Is It Time To Put Humana AB (publ) (STO:HUM) On Your Watch List?

Investor sentiment deteriorates as stock falls 50%

Humana AB (publ) to Report Nine Months, 2023 Results on Nov 09, 2023

Price target decreased by 7.8% to kr59.33

Price target decreased to kr60.33

Humana AB (Publ) Announces Management Changes

Price target decreased to kr64.33

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Humana AB (publ) to Report Q1, 2023 Results on May 04, 2023

Sön Mellllstig, Chairman of the Board of Humana Ab, Is Not Available for Re-Election at the 2023 Annual General Meeting

Is Humana (STO:HUM) Using Too Much Debt?

Humana AB Announces Nomination Committee for 2023 AGM

Consensus forecasts updated

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Independent Chairman of the Board recently bought kr38m worth of stock

Noora Jayasekara Leaves Humana Member of Group Management

Humana AB (publ) (OM:HUM) acquired Vintergatan AB.

Humana AB (publ) (OM:HUM) completed the acquistion of Assistans For Dig I Sverige Ab.

Humana AB (publ) (OM:HUM) agreed to acquire Assistans For Dig I Sverige Ab for approximately SEK151 million.

Price target decreased to kr79.00

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased to kr81.50

Full year 2021 earnings: Revenues in line with analyst expectations

Is It Too Late To Consider Buying Humana AB (publ) (STO:HUM)?

Humana AB (publ) to Report Q3, 2022 Results on Nov 10, 2022

President & CEO recently bought kr180k worth of stock

President & CEO recently bought kr200k worth of stock

Consensus EPS estimates fall by 11%

Price target decreased to kr86.50

Full year 2021 earnings: EPS misses analyst expectations

Investor sentiment deteriorated over the past week

Now 24% undervalued after recent price drop

Humana AB (publ) (OM:HUM) acquired Kalliola Oy - Uudet Setlementtiratkaisut.

Is Humana (STO:HUM) Using Too Much Debt?

Third quarter 2021 earnings released: EPS kr2.54 (vs kr2.05 in 3Q 2020)

Price target increased to kr97.50

Director of Marketing & Communication Helena Pharmanson has left the company

Director of Human Resources Anna Skablova has left the company